Published in Q Magn Reson Biol Med on January 01, 0001
Functional diffusion map: a noninvasive MRI biomarker for early stratification of clinical brain tumor response. Proc Natl Acad Sci U S A (2005) 4.63
Evaluation of the functional diffusion map as an early biomarker of time-to-progression and overall survival in high-grade glioma. Proc Natl Acad Sci U S A (2005) 3.15
Functional diffusion map as an early imaging biomarker for high-grade glioma: correlation with conventional radiologic response and overall survival. J Clin Oncol (2008) 2.84
The functional diffusion map: an imaging biomarker for the early prediction of cancer treatment outcome. Neoplasia (2006) 2.30
Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia (1999) 2.24
Predicting and monitoring cancer treatment response with diffusion-weighted MRI. J Magn Reson Imaging (2010) 1.82
A feasibility study evaluating the functional diffusion map as a predictive imaging biomarker for detection of treatment response in a patient with metastatic prostate cancer to the bone. Neoplasia (2007) 1.50
Diffusion imaging for evaluation of tumor therapies in preclinical animal models. MAGMA (2004) 1.33
Voxel-by-voxel functional diffusion mapping for early evaluation of breast cancer treatment. Inf Process Med Imaging (2009) 1.15
Diffusion magnetic resonance imaging: an imaging treatment response biomarker to chemoradiotherapy in a mouse model of squamous cell cancer of the head and neck. Transl Oncol (2008) 1.09
Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance. NMR Biomed (2006) 0.97
DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma. PLoS One (2012) 0.96
Evaluation of treatment-associated inflammatory response on diffusion-weighted magnetic resonance imaging and 2-[18F]-fluoro-2-deoxy-D-glucose-positron emission tomography imaging biomarkers. Clin Cancer Res (2010) 0.90
Whole body diffusion weighted MRI--a new view of myeloma. Br J Haematol (2015) 0.89
Synergy between anti-CCL2 and docetaxel as determined by DW-MRI in a metastatic bone cancer model. J Cell Biochem (2009) 0.88
Assessment of multiexponential diffusion features as MRI cancer therapy response metrics. Magn Reson Med (2010) 0.85
Multi-site clinical evaluation of DW-MRI as a treatment response metric for breast cancer patients undergoing neoadjuvant chemotherapy. PLoS One (2015) 0.83
Integrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer. PLoS One (2015) 0.79
Advanced MRI: translation from animal to human in brain tumor research. Neuroimaging Clin N Am (2009) 0.75
Diffusion-weighted magnetic resonance imaging in predicting the radiosensitivity of cervical cancer. Int J Clin Exp Med (2015) 0.75
Predicting treatment efficacy via quantitative magnetic resonance imaging: a Bayesian joint model. J R Stat Soc Ser C Appl Stat (2011) 0.75
In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science (1992) 5.47
NMR chemical shift imaging in three dimensions. Proc Natl Acad Sci U S A (1982) 4.95
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Anisotropic diffusion in human white matter: demonstration with MR techniques in vivo. Radiology (1990) 4.42
ADP-ribosylation. Annu Rev Biochem (1985) 3.30
Tumor chemosensitivity conferred by inserted herpes thymidine kinase genes: paradigm for a prospective cancer control strategy. Cancer Res (1986) 2.98
Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. J Neurosurg (1977) 2.39
In vivo clonogenic tumor cell kinetics following 1,3-bis(2-chloroethyl)-1-nitrosourea brain tumor therapy. Cancer Res (1976) 2.04
Hydrogen peroxide-induced injury of cells and its prevention by inhibitors of poly(ADP-ribose) polymerase. Proc Natl Acad Sci U S A (1986) 1.87
Molecular diffusion nuclear magnetic resonance imaging. Magn Reson Q (1991) 1.85
Development of an animal brain tumor model and its response to therapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1973) 1.51
Gene therapy for the treatment of brain tumors using intra-tumoral transduction with the thymidine kinase gene and intravenous ganciclovir. Hum Gene Ther (1993) 1.44
In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res (1975) 1.37
The 9L rat brain tumor: description and application of an animal model. J Neurol (1981) 1.11
Reversible oxidation of glyceraldehyde 3-phosphate dehydrogenase thiols in human lung carcinoma cells by hydrogen peroxide. Biochem Biophys Res Commun (1987) 1.05
Brain-tumor therapy. Quantitative analysis using a model system. J Neurosurg (1977) 1.05
In vivo 31P and 2H NMR [corrected] studies of rat brain tumor pH and blood flow during acute hyperglycemia: differential effects between subcutaneous and intracerebral locations. Magn Reson Med (1989) 1.03
The effect of thymidine kinase transduction and ganciclovir therapy on tumor vasculature and growth of 9L gliomas in rats. J Neurosurg (1994) 1.01
Toxicity studies of retroviral-mediated gene transfer for the treatment of brain tumors. J Neurosurg (1993) 0.98
Animal models for brain tumors: historical perspectives and future directions. J Neurosurg (1994) 0.96
Carbohydrate metabolism of the rat C6 glioma. An in vivo 13C and in vitro 1H magnetic resonance spectroscopy study. NMR Biomed (1988) 0.96
Is cell survival a determinant of the in situ response of 9L tumours? Br J Cancer Suppl (1980) 0.95
Cancer chemotherapy: new strategies for success. J Clin Invest (1986) 0.89
Magnetic resonance imaging with adiabatic pulses using a single surface coil for RF transmission and signal detection. Magn Reson Med (1989) 0.89
Comparison of clonogenic cell assays after in vivo and in vitro treatment of 9L gliosarcoma. Br J Cancer Suppl (1980) 0.85
Response of tumours to hyperglycaemia: characterization, significance and role in hyperthermia. Int J Hyperthermia (1988) 0.85
Efficacy of continuous treatment with radiation in a rat brain-tumor model. J Neurosurg (1981) 0.84
Ascorbic acid enhances the effects of 6-hydroxydopamine and H2O2 on iron-dependent DNA strand breaks and related processes in the neuroblastoma cell line SK-N-SH. Cancer Res (1991) 0.83
Combination chemotherapy for the 9L rat brain tumor model system. Cancer Treat Rep (1982) 0.83
Regression of human breast tumor xenografts in response to (E)-2'-deoxy-2'-(fluoromethylene)cytidine, an inhibitor of ribonucleoside diphosphate reductase. Cancer Res (1994) 0.83
Brain tumors: criteria of response and definition of recurrence. Natl Cancer Inst Monogr (1977) 0.82
Quantitative determination of tumor blood flow and perfusion via deuterium nuclear magnetic resonance spectroscopy in mice. Cancer Res (1988) 0.81
Spatially localized in vivo 1H magnetic resonance spectroscopy of an intracerebral rat glioma. Magn Reson Med (1992) 0.81
Effect of glucose and galactose on microcirculatory flow in normal and neoplastic tissues in rabbits. Cancer Res (1987) 0.81
Oxidation therapy: the use of a reactive oxygen species-generating enzyme system for tumour treatment. Br J Cancer (1994) 0.80
Quantitation of tumor response to anti-neoplastic therapy. Semin Oncol (1988) 0.78
Effect of lonidamine on the utilization of 14C-labeled glucose by human astrocytoma cells. Exp Mol Pathol (1987) 0.78
Post-treatment kinetics of BCNU in a 9L rat brain tumor model. Neurol Med Chir (Tokyo) (1981) 0.78
Spin saturation artifact correction using slice-to-volume registration motion estimates for fMRI time series. Med Phys (2008) 0.83
Formulation of current density weighted indices for correspondence between functional MRI and electrocortical stimulation maps. Clin Neurophysiol (2008) 0.80
Motion robust magnetic susceptibility and field inhomogeneity estimation using regularized image restoration techniques for fMRI. Med Image Comput Comput Assist Interv (2008) 0.79
Improved map-slice-to-volume motion correction with B0 inhomogeneity correction: validation of activation detection algorithms using ROC curve analyses. Med Image Comput Comput Assist Interv (2006) 0.79
Zero and first-order phase shift correction for field map estimation with dual-echo GRE using bipolar gradients. Magn Reson Imaging (2007) 0.79
Accelerated nonrigid intensity-based image registration using importance sampling. IEEE Trans Med Imaging (2009) 0.78
Evaluation of (E)-2'-deoxy-2'-(fluoromethylene)cytidine on the 9L rat brain tumor model using MRI. NMR Biomed (2003) 0.77
Concurrent correction of geometric distortion and motion using the map-slice-to-volume method in echo-planar imaging. Magn Reson Imaging (2008) 0.76
Retrospective estimation of the susceptibility driven field map for distortion correction in echo planar imaging. Inf Process Med Imaging (2013) 0.75